Intratumoral delivery of STING agonist results in clinical responses in canine glioblastoma

CE Boudreau, H Najem, M Ott, C Horbinski… - Clinical Cancer …, 2021 - AACR
Purpose: Activation of STING (s timulator of in terferon g enes) can trigger a robust, innate
antitumor immune response in immunologically “cold” tumors such as glioblastoma. Patients …

Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene …

AM Brooks, A Vornoli, RC Kovi, TVT Ton, M Xu… - Plos one, 2024 - journals.plos.org
The cancer hazard associated with lifetime exposure to radiofrequency radiation (RFR) was
examined in Sprague Dawley (SD) rats at the Ramazzini Institute (RI), Italy. There were …

Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model

G Alberti, MD Amico, C Caruso Bavisotto… - International Journal of …, 2024 - mdpi.com
Glioblastoma multiforme (GBM) is a very aggressive and lethal primary brain cancer in
adults. The multifaceted nature of GBM pathogenesis, rising from complex interactions …

Intra-and Intertumoral Microglia/Macrophage Infiltration and Their Associated Molecular Signature Is Highly Variable in Canine Oligodendroglioma: A Preliminary …

RG Toedebusch, NW Wei, KT Simafranca… - Veterinary …, 2023 - mdpi.com
Simple Summary Canine oligodendrogliomas are universally fatal primary brain tumors.
Glioma-associated microglia/macrophages (GAMs) have been shown to contribute to …

Epigenetic targeting of cancer

J Cawley - Therapeutic Strategies in Veterinary Oncology, 2023 - cabidigitallibrary.org
9 Gene Editing and Gene Therapy in Oncology Page 1 9 Gene Editing and Gene Therapy
in Oncology WESLEY A. WIERSON 1*, ALEX M. ABEL 1, ELIZABETH L. SIEGLER 2 …

Microbiome in cancer: A comparative analysis between humans and dogs

L Guardone, V Listorti, R Elisabetta - The Veterinary Journal, 2024 - Elsevier
Cancer is a major cause of death in humans and animals worldwide. While cancer survival
rates have increased over recent decades, further research to identify risk factors for the …

cTULIP: application of a human-based RNA-seq primary tumor classification tool for cross-species primary tumor classification in canine

J Long, SR Ganakammal, SE Jones… - Frontiers in …, 2023 - frontiersin.org
Introduction The domestic dog, Canis familiaris, is quickly gaining traction as an
advantageous model for use in the study of cancer, one of the leading causes of death …

The T2‐FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs

J Garcia‐Mora, RL Parker, T Cecere… - Journal of Veterinary …, 2023 - Wiley Online Library
Background In humans, the T2‐weighted (T2W)—fluid‐attenuated inversion recovery
(FLAIR) mismatch sign (T2FMM) is a specific imaging biomarker for the isocitrate …

The NRG3/ERBB4 signaling cascade as a novel therapeutic target for canine glioma

S Noguchi, M Inoue, T Ichikawa, K Kurozumi… - Experimental Cell …, 2021 - Elsevier
Canine glioma is a common brain tumor with poor prognosis despite surgery and/or
radiation therapy. Therefore, newer and more effective treatment modalities are needed …

The relationships of platelet-derived growth factor, microvascular proliferation, and tumor cell proliferation in canine high-grade oligodendrogliomas …

K Yoshida, JK Chambers, K Uchida - Veterinary Pathology, 2024 - journals.sagepub.com
High-grade oligodendroglioma (HGOG) is the most common type of glioma in dogs and
expresses platelet-derived growth factor receptor-α (PDGFR-α). Microvascular proliferation …